2024-11-0920161048-891XN/AN/Ahttps://hdl.handle.net/20.500.14288/15501N/AOncologyObstetricsGynecologyHow can optimal cytoreduction rates increased over ninety percent with a minimal usage of neoadjuvant chemotherapy ?Meeting Abstract1525-1438387109100651Q18237